A Prospective, Trial About Safety and Efficacy of Combined Treatment With Cerebrolysin in Acute Ischemic Hemispheric Stroke Patients Undergoing EndoVascular Treatment (EVT)

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

June 30, 2024

Study Completion Date

December 30, 2024

Conditions

Acute Ischemic Stroke

Interventions

DRUG

Cerebrolysin

Cerebrolysin, 30 ml/day as intravenous infusion, first infusion after completion of EVT. Daily infusion for 10 consecutive days.

Trial Locations (1)

RECRUITING

Shaare Zedek Medical Center, Jerusalem

All Listed Sponsors

lead

Shaare Zedek Medical Center

OTHER